Online Media Kit


March 06, 2018 | POZ

Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study

The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »


December 19, 2017 | BBC World Hacks

The Ring That Could Help Save Women's Lives (AUDIO)

A new form of protection being tested in Malawi could be a real game-changer. World Hacks meets the women pioneering this approach and taking control of their own protection. More »


May 04, 2017 | Economist (UK)

How to protect women against both HIV and pregnancy

A newly-developed vaginal ring releases small doses of drugs over a three-month period More »


February 26, 2016 | The New York Times editorial

Helping Women in Africa Avoid H.I.V.

Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »

Media Highlights

November 10, 2019 | Health Policy Watch

Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis

A side event ahead of the Global Fund’s Sixth Replenishment Conference. co-sponsored by IPM, highlighted the role of PDPs in advancing global health innovation. More »

September 02, 2019 | Medscape (France)

La PrEP s’étoffe avec un implant sous-cutané et un anneau vaginal à libération prolongée d'ART

Results from the HOPE study of the dapivirine vaginal ring were presented at IAS 2019. More »

August 06, 2019 | Healio

HOPE trial: Dapivirine vaginal ring reduces HIV risk by estimated 39%

 “The more options that are developed and used, the better chance we have to turn the tide on the global HIV epidemic,” Baeten said. More »

July 29, 2019 | HIV Plus Magazine

Vaginal Ring Brings New Hope For HIV Prevention in Women

The HOPE study shows high levels of adherence and effectiveness for a new kind of PrEP for women.  More »

July 27, 2019 | Aidsmap (UK)

Dapivirine vaginal ring effective and acceptable with longer use

The dapivirine ring was well tolerated and acceptable in the HOPE trial, which also estimated a reduction in HIV risk. More »